BioSpace News Archive

Policy

STEMCELL Submits Drug Master File for mTeSR™1, the Most Widely Published Cell Culture Medium for Human Pluripotent Stem Cells

STEMCELL Technologies announced it has filed a Type II Drug Master File (DMF) to the Food and Drug Administration (FDA) for the Cellular Therapy Ancillary Material mTeSR™1 and has been issued DMF# 18339.

October 23, 2018
·
2 min read
Business

Sage Therapeutics to Report Third Quarter 2018 Financial Results on Tuesday, November 6, 2018

Sage Therapeutics today announced that the company will host a conference call and live webcast on Tuesday, November 6, 2018 at 8:00 A.M. ET to report its third quarter 2018 financial results and to discuss recent business updates.

October 23, 2018
·
1 min read
Business

Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research Collaboration

The companies will collaborate on the discovery of novel monospecific antibodies to develop bispecific therapeutics targeting cytokine-receptor pathways with applications in dermatology, inflammation, and autoimmunity by leveraging Zymeworks’ Azymetric™ and EFECT™ therapeutic platforms

October 23, 2018
·
7 min read
Business

Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2018 Financial Results

Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the third quarter 2018 on Tuesday, Nov. 6 at 9 a.m. ET.

October 23, 2018
·
1 min read
Biotech Bay

Reckitt Benckiser (RB) and VivaLNK Partner to Bring Parents Peace of Mind with Wearable Continuous Temperature Monitor Worldwide

VivaLNK announces today a partnership with Reckitt Benckiser (RB) to market and distribute VivaLNK’s wearable continuous temperature monitor worldwide.

October 23, 2018
·
2 min read
Drug Development

Ocugen to Highlight Phase 2 Clinical Data for OCU310 at AAO 2018

The poster will highlight the tolerability and preliminary efficacy results from a randomized Phase 2 proof-of-concept study in patients with DED.

October 23, 2018
·
2 min read
Biotech Bay

Synthego Receives $110M in Funding to Accelerate Global Access to Genome Engineering

Series C investment expedites Synthego’s CRISPR product expansion to facilitate industry development of new therapies, adds cell therapy pioneer Dr. Matthew Porteus to advisory board

October 23, 2018
·
4 min read
Drug Development

KN035, a Global Leading Subcutaneously-administered PD-L1 Antibody, Starts Late-stage Clinical Development

KN035’s US Phase I clinical data was presented at the annual ESMO Congress

October 23, 2018
·
3 min read
Pharm Country

Smile Train Celebrated Its 100,000th Cleft Surgery Milestone in Africa

From October 21-22, Smile Train, the world’s largest cleft organization, celebrated its 100,000th cleft surgery milestone in Africa with a number of different activities planned each day.

October 23, 2018
·
3 min read
Pharm Country

Dominion Diagnostics recognized for expanded testing launch and poised for new clinical research partnerships

Dominion Diagnostics is a well-respected, trusted healthcare company with over two decades of experience and expertise delivering patient-centered drug monitoring solutions, improved treatment outcomes and actionable clinical information to inform care.

October 23, 2018
·
3 min read